HK Stock Market Move | ASMPT (00522) rose by more than 5% and broke through the top again. The company is expected to add Samsung as its second major customer, solidifying its leadership position in TCB.
ASMPT (00522) rose more than 5% in early trading, reaching a high of 139.7 Hong Kong dollars, hitting a new record high. As of the time of writing, it had risen by 4.74% to 139.1 Hong Kong dollars, with a trading volume of 2.59 billion Hong Kong dollars.
ASM Pacific Technology (00522) rose more than 5% in the morning session, reaching a high of 139.7 Hong Kong dollars, setting a new historical high. As of the time of writing, it has risen by 4.74% to 139.1 Hong Kong dollars, with a turnover of 2.59 billion Hong Kong dollars.
According to media reports, ASMPT recently showcased its HBM TCB technology to Samsung Electronics, with the project entering the mutual evaluation phase. Citigroup stated that ASMPT's stock price has broken through the historical resistance level of 120 Hong Kong dollars for the first time since 2021, and believes that the strong performance of the stock price is mainly driven by the above-mentioned reports. If the news is true, ASMPT is expected to add Samsung as its second major customer, further solidifying its leading position in the TCB market.
Huatai has previously mentioned that there is a strong demand for advanced packaging: with the iteration of higher HBM layers and the evolution of more complex advanced packaging architectures, equipment such as TCB is expected to see a strong conversion of orders. Asset structure optimization will enhance profitability: by divesting non-core assets, the company may focus more on advanced packaging business, and the long-term profit margin is expected to further increase.
Related Articles

New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.
New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


